Aion Launch

0 views

Skip to first unread message

Hedvig Horning

unread,

Aug 3, 2024, 12:14:29 PM8/3/24

to silcessderra

Sometimes when I launch Aion on my laptop, I sign in and click play and all that, but a few seconds after the splash screen shows up, it simply disappears. No "Aion has stopped working" or anything like that. It just goes away. I've tried rebooting my computer and checking the disk (found to do that on another forum with a similar issue), but nothing has worked. Once when I tried recording a video of the process it started working again. I didn't do anything different. Now about a week later it's doing the same thing: crashing almost immediately after the splash screen comes up. The XIGNCODE3 popup doesn't appear, so I think it might be an issue with that? Either way I have no clue how to resolve it.

save this without quotes in a text document, then change the file extension from .txt to .bat and run it as admin to kill the task without needing to use task manager. Just make sure the file is accessible on a monitor the game doesn't load on.

The pop up will show for a while but will suddenly close and the game never launches. Yes, I do get the XIGNCODE3. I have tried everything. Changing compatibility mode (both on and set to windows 8 and also off), I have renamed AION.bin to AION.bin.old, I have uninstalled and reinstalled, I have even tried turning off Bluetooth. Somebody, please help me.

Not that I know of, but I'm not sure what programs would affect it. If you're talking about security programs, all I use is MCAFEE and Norton. I've also tried having everything else closed when launching.

We have been hard at work on PURPLE and are excited to finally bring our new launcher to NCA Players on Tuesday, March 12th! We will soon release more details regarding the maintenance session required to migrate all player accounts and games to the new launcher. Please stay tuned!

If you have not prepared for the migration of your account yet, please check out our Migration Guide and head to our Discord if you have any questions or issues. You can head to #purple-chat, which is an entire channel dedicated to helping you with PURPLE migration questions.

We are delighted to be launching PURPLE Lounge, a brand-new hub for finding game news and other related content in one centralized location. You will be able to access PURPLE Lounge via PC app, web, and PURPLE Mobile.

Lounge will offer a daily feed full of game news, announcements, event info, game webtoons, and more! We will be continuously updating and improving PURPLE Lounge. In the meantime, please share your opinions and content you would like to see on Discord!

Another great feature of PURPLE Talk is the ability to quickly find in-game players and invite them to your Chat Room or House. All installed games should give you the ability to search for certain players in the chosen game!

Once you are streaming, there are several options, including the ability to share via URL. By sharing a URL link to your stream, you can invite other PURPLE users to your stream. All viewers must log into PURPLE to view the stream.

We are looking forward to exploring even more features for PURPLE and our games in the future, including new security measures. Please continue to send your feedback to our team via Discord and we look forward to enjoying a new launcher and platform with you all!

REHOVOT, Israel, Oct. 13, 2021 /PRNewswire/ -- AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, today announced its official launch and the opening of its international headquarters.

AION Labs will create and invest in early-stage start-up teams focused on AI and computational biology in drug discovery and development, offering each of them top-notch resources and mentorship while working closely with them to develop new technologies that meet the most acute and significant challenges in the pharmaceutical industry. Each start-up will harness the power of artificial intelligence, and scale and security of the cloud, to find new treatments faster and more efficiently, avoid animal experiments, and advance healthcare towards patient-centric precision medicine.

AION Labs also announced today that Mati Gill, a former senior executive at Teva Pharmaceuticals, has been appointed CEO of the lab, and former head of computational biology at Compugen and science operations at CytoReason and principal scientist at MSD, Yair Benita, Ph.D., has been appointed CTO.

"We are excited to launch our new Innovation Lab for new drug and device discoveries," said Mati Gill, CEO of AION Labs. "Our R&D needs-based approach, coupled with our outstanding alliance, is poised to transform the process of therapeutic discovery and development. With a strong talent pool, AI technology at our core and a significant commitment of the Israeli government, we hope to contribute to the health and well-being of humankind. I'm honored to lead such a meaningful initiative, and to work closely with our consortium members to solve many of the world's critical health issues."

In addition, AION Labs has announced its strategic partnership with BioMed X, an independent biomedical research institute based in Heidelberg, Germany. BioMed X has a strong track record of seeding biomedical innovations at the interface between academic research and the pharmaceutical industry. BioMed X's innovation model, based on global crowdsourcing and local incubation of the brightest research talents and ideas, will serve as the R&D engine to propel AION Lab's venture creation model.

"We are excited to extend our successful innovation model to Israel," said Christian Tidona, Founder and Managing Director of BioMed X. "In our view, Israel is currently the best place to jointly leverage the power of artificial intelligence for drug discovery and development together with leading global players in pharmaceuticals, tech and venture capital."

AION Labs will include both a wet lab, where biomedical research will be performed, and a cloud-based computational lab environment, focusing on the development of new algorithms and computational methods with the aim of accelerating the discovery and development of potential new therapies.

"AION Labs is an excellent example of what Pfizer seeks to help build through collaboration within biopharma and across industries: a program with the potential to accelerate the development of meaningful breakthroughs that could change patients' lives," said Uwe Schoenbeck, Ph.D., Senior Vice President and Chief Scientific Officer for Emerging Science & Innovation, Pfizer. "We look forward to playing a pivotal role in AION's pursuit of innovation."

Jim Weatherall, Vice President, Data Science and AI, R&D, AstraZeneca said: "Data, analytics and AI are already starting to transform the way we discover and develop new medicines and I believe we are only at the tip of the iceberg in terms of its promise. Through AION Labs we have the potential to solve some of the greatest R&D challenges and find new and better ways to discover, test and accelerate the potential medicines of tomorrow. I look forward to helping form the challenges and select and mentor the companies that will enter the Lab."

Joern-Peter Halle, Head of Global Research at the Healthcare Business Sector of Merck said: "The AION Labs build on our longstanding and successful investments in innovation coming out of Israel. We are excited to work with the partners to create tangible value in applying AI to drug discovery and development in the biopharmaceutical industry and make virtual drug discovery a reality."

"Teva is truly excited to collaborate with top pharma, high-tech and investment companies to assemble this unique biotech venture to develop novel therapeutic treatments," said Dr. Eran Harary, Global Head of Specialty R&D at Teva Pharmaceuticals. "The way we discover and develop new drugs is undergoing transformation. AI technologies and cross-industry collaborations will play an increasingly significant role in revolutionizing the way we address unmet patient needs. We are especially proud to continue our innovative work with the Israeli healthcare and biotech ecosystem and look forward to seeing the fruits of this new collaboration," added Dr. Harary.

"We are thrilled to be part of this first of its kind innovation lab led by an outstanding group of international pharma and tech companies" said Ido Zairi, Founder & Managing Partner of IBF. "The lab's dedication to ameliorating the biotech industry by developing cutting-edge technologies and solutions and embedding them in pharma aligns with IBF's goals."

Dror Bin, CEO of the Israel Innovation Authority: "The Innovation Authority congratulates the companies involved in the establishment of this innovation lab as part of the Innovation Authority's strategy to develop an ecosystem of researchers, entrepreneurs, and companies and the growing field of Bio-Convergence for innovative and disruptive technologies relating to the future of medicine. Fusing the world of biology with various disciplines of software in which Israel has global leadership will lead to the creation of cutting-edge companies and a globally innovative ecosystem."

AION Labs is a first-of-its-kind alliance of six global pharma and tech leaders that have come together with one clear mission: to create and adopt groundbreaking new AI technologies that will transform the process of drug discovery and development in order to contribute to the health and well-being of all people world-wide.